Mr. Nativ Segev is a Co-Founder of MGC Pharmaceuticals Limited and serves as its and Managing Director. Mr. Segev served as the Chief Executive Officer of Israel’s second largest licensed Medical Cannabis company, Cann Pharmaceuticals, known as Better Cannabis and led it from start-up through to a large private equity investment. Over 5 years experience in the MGC industry. He served as Chief Executive Officer of Cann Pharmaceuticals, a leader in industrial medical cannabis manufacturing and system design. During these years, he was leading the Medical Cannabis regulation in Israel and the Czech Republic alongside with developing new medical treatments and spearheading the discovery of new strains. Mr. Segev has been a Director of MGC Pharmaceuticals Limited since January 22, 2016.
MXC Price at posting:
6.6¢ Sentiment: Hold Disclosure: Held
